Amendments to Chinese Patents Law for the Life Sciences

09-09-2021

Keith Haddaway and Christopher Loh

Amendments to Chinese Patents Law for the Life Sciences

crystal51 / Shutterstock.com

Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.

On June 1, 2021, the fourth amendment of the Chinese patent law went into effect. The amendment contains generally applicable provisions and makes specific changes to design patent law and Life Science-related patents.

Alongside this, the Chinese National Intellectual Property Administration (CNIPA) issued revised patentability guidelines in January 2021 directed to patent prosecution in the Life Sciences.

Fourth amendment – linkage system


Patents, life sciences, litigation, CNIPA, design law, Hatch Waxman, biologics, medical use, statutory damages, novelty, invention

LSIPR